Related Experiment Video

Updated: Jun 5, 2026

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
04:48

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

NAD+ treatment decreases tumor cell survival by inducing oxidative stress

Cuiping Zhao1, Yunyi Hong, Jin Han

  • 1Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, PR China.

Frontiers in Bioscience (Elite Edition)
|January 4, 2011
PubMed

Insights

Nicotinamide adenine dinucleotide (NAD+) treatment significantly reduces tumor cell survival by inducing oxidative stress. This selective effect on cancer cells suggests NAD+ as a potential novel cancer therapeutic agent.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Nicotinamide adenine dinucleotide (NAD+) is crucial for biological processes.
  • NAD+ administration protects against brain damage and genotoxic agents.
  • The impact of NAD+ on tumor cell survival remains unexplored.

Purpose of the Study:

  • To investigate the effects of NAD+ on the survival of various tumor cell types.
  • To elucidate the mechanisms underlying NAD+'s influence on tumor cell viability.
  • To assess the potential of NAD+ as an anti-cancer therapeutic.

Main Methods:

  • Treatment of C6 glioma and primary astrocyte cultures with NAD+ at varying concentrations (10 micromolar to 1 mM).
  • Assessment of cell survival rates post-NAD+ exposure.
  • Analysis of the roles of oxidative stress, P2X7 receptors, and calcium homeostasis.

Main Results:

  • NAD+ treatment significantly decreased the survival of C6 glioma cells and other tumor cell types.
  • NAD+ did not impair the survival of primary astrocyte cultures, indicating selectivity.
  • Oxidative stress, P2X7 receptors, and altered calcium homeostasis were identified as key mediators.

Conclusions:

  • NAD+ selectively reduces tumor cell survival, distinct from its effects on normal cells.
  • The anti-tumor effects of NAD+ are mediated by induced oxidative stress.
  • NAD+ presents a promising novel therapeutic strategy for cancer treatment.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...